Isabelle Fontaine

Former pharma sales rep who got disillusioned with the spin. Now writes independently about reading health studies critically.

Articles by Isabelle Fontaine

Latest Posts

Science

Blood Pressure Therapy Cuts Death Risk in Metastatic Breast Cancer

Managing High Blood Pressure Improves Survival in Advanced Breast Cancer Patients Women diagnosed with metastatic breast cancer frequently deal with a range of ongoing health issues, and elevated blood pressure stands out as one of the most prevalent among them. In the cohort examined in this research, close to 50% of the participants were already […]

Read

Nutrition

Quick Cottage Cheese Shrimp Alfredo Pasta

Cottage cheese Alfredo stands out as a fantastic weeknight solution that delivers a luxurious feel with minimal effort required. This recipe captures the rich, comforting essence of traditional fettuccine Alfredo, but it relies on everyday pantry staples and comes together effortlessly. The sauce achieves a velvety texture in just moments, while the addition of shrimp […]

Read

Nutrition

Lactose Intolerance Does Not Require Giving Up All Dairy

Understanding Lactose Intolerance and Its Impact on Daily EatingReceiving a diagnosis of lactose intolerance often leads individuals to believe that every form of dairy must be completely eliminated from their meals. This assumption can quickly create feelings of stress and limitation around food ch

Read

Lifestyle

Safe Winter Driving: Icy Road Survival Guide

Winter Driving Safety: Essential Guide for Icy Roads Winter transforms scenic landscapes into picturesque scenes, yet it simultaneously introduces hazardous conditions for motorists. Slick ice patches that are nearly undetectable, combined with intense snowfalls, challenge every journey and demand sharp winter driving expertise. To safeguard yourself and your fellow passengers, thorough preparation is key for […]

Read

Science

Antibiotics Boost TBI Recovery via Gut-Brain Axis

Researchers from Houston Methodist, under the leadership of Sonia Villapol, Ph.D., have published groundbreaking findings in Communications Biology, demonstrating that a brief course of antibiotics can substantially diminish neuroinflammation and neurodegeneration in the aftermath of traumatic brain injury (TBI). This effect is achieved through targeted modifications to the gut microbiome in experimental animal models. Villapol, […]

Read

Nutrition

Boost Brain Fog Relief: Creatine for Sharper Thinking

Brain fog can significantly impair your ability to think clearly. It might manifest as overlooking minor details in a professional assignment or failing to pick up that essential item during a grocery run—the very reason you went shopping in the first place. This issue extends beyond just older individuals. A comprehensive study published in Neurology, […]

Read

Science

Trump’s Leg Swelling: CVI Risk Alert for Millions

Following recent White House disclosures about President Donald J. Trump’s diagnosis of Chronic Venous Insufficiency (CVI), the American Heart Association has stepped forward to provide essential details on this condition and its notable connections to cardiovascular risk elements, diseases, and elevated mortality rates. The Association, recognized globally as the premier nonprofit dedicated to promoting heart […]

Read

Science

Trusted Bottled Water Often Riskiest in Guatemala Study

A recent investigation conducted by researchers from Washington State University in Guatemala’s Western Highlands has uncovered a startling reality: the drinking water sources that local residents consider the most reliable may actually pose the greatest health risks. Specifically, bottled water dispensed from large refillable containers, which many people regard as the ultimate safe option, was […]

Read

Science

Orforglipron Pill Surpasses Semaglutide in Diabetes Trial

A groundbreaking oral medication known as orforglipron, which functions as a GLP-1 receptor agonist, has demonstrated superior performance in lowering blood sugar levels over a full year when compared to the existing oral GLP-1 receptor agonist semaglutide, according to results from a phase 3 randomized controlled clinical study detailed in The Lancet. Moreover, individuals participating […]

Read